Transplantation of hearts from SARS‐CoV‐2 positive donors

Abstract Incidence of SARS‐CoV‐2 remains high in the population. Consequently, an increasing percentage of reported organ donors are also SARS‐CoV‐2 positive. Although donors may not have experienced COVID‐19‐related symptoms, there is a chance of unnoticed cardiovascular effects associated with this disease. Therefore, SARS‐CoV‐2 donor grafts have been regularly rejected for heart transplantation (HTx) for a long time. We hereby present three consecutive patients receiving grafts from SARS‐CoV‐2 positive donors (defined by the PCR cycle threshold value